Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting stem cells in brain tumors.

Joseph L Lasky1, Linda M Liau

  • 1Division of Neurosurgery, David Geffen School of Medicine at UCLA, University of California at Los Angeles, Los Angeles, CA 90095, USA.

Technology in Cancer Research & Treatment
|May 17, 2006
PubMed
Summary

Cancer stem cells (CSCs) drive tumor formation and heterogeneity. Targeting these self-renewing brain cancer stem cells offers a path toward more effective and less toxic therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictable clonal hierarchies from restricted progenitors provide a framework for cell type-specific therapies in glioblastoma.

bioRxiv : the preprint server for biology·2026
Same author

A single-institution retrospective study of multicentric gliomas stratified by <i>IDH</i> mutational status.

Neuro-oncology advances·2026
Same author

Clinical and radiographic prognostic factors in recurrent contrast-enhancing IDH-mutant gliomas treated with bevacizumab.

Neuro-oncology advances·2026
Same author

Therapeutic efficacy of dendritic cell vaccination in a novel syngeneic mouse model of diffuse hemispheric glioma, H3 G34-mutant.

Journal of neuro-oncology·2026
Same author

MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapy.

Journal of neuro-oncology·2026
Same author

Vaccine therapy for pediatric high-grade glioma: current landscape, challenges, and future directions.

Journal of neuro-oncology·2026

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Neuro-oncology

Background:

  • Stem cells are undifferentiated cells with self-renewal and differentiation capabilities.
  • Cancer stem cells (CSCs) are a subpopulation of cancer cells responsible for tumor initiation and heterogeneity.
  • Current therapies often fail to eradicate CSCs due to their self-renewal and quiescent properties.

Purpose of the Study:

  • To review the discovery and properties of brain cancer stem cells (BCSCs).
  • To discuss the implications of BCSCs in human brain tumors.
  • To explore therapeutic strategies targeting BCSCs.

Main Methods:

  • Review of recent scientific literature on cancer stem cells and brain tumors.
  • Analysis of the characteristics of self-renewal and differentiation in BCSCs.
  • Discussion of molecular mechanisms underlying CSC self-renewal and quiescence.

Main Results:

  • Identification of stem cell-like cells in human brain tumors, termed brain cancer stem cells (BCSCs).
  • BCSCs exhibit self-renewal and the ability to generate the diverse cell types found in the original tumor.
  • BCSCs possess mechanisms for self-renewal and maintaining quiescence, contributing to therapeutic resistance.

Conclusions:

  • Brain cancer stem cells are a critical target for novel therapeutic interventions.
  • Understanding the molecular basis of BCSCs' self-renewal and quiescence is key to developing new treatments.
  • Targeting BCSCs may lead to more efficacious and less toxic therapies for brain malignancies.

Related Experiment Videos